Cargando…

Direct-acting Anticoagulants in Chronic Coronary Syndromes

Direct-acting oral anticoagulants (DOACs) are easier to use, safer than and as effective as vitamin K antagonists (VKA) in the treatment of non-valvular AF (NVAF). Because of their favourable safety profile and easier use than VKAs, DOACs as anti-thrombotic therapy may have a role in the management...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorbets, Emmanuel, Steg, Philippe Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066807/
https://www.ncbi.nlm.nih.gov/pubmed/32180831
http://dx.doi.org/10.15420/ecr.2018.24.2

Ejemplares similares